John Dobak, Chief Executive Officer at DermTech, Inc. (DMTK), sold 50,000 shares at $42.45 ($2.0M) on 2021-05-03, disclosed to the SEC on 2021-05-05.
Open-market sale of $2.0M DMTK by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.51 | 16,021 | $649K | 31.7% |
| 2 | $40.51 | 16,021 | $649K | 31.7% |
| 3 | $41.53 | 6,808 | $283K | 13.8% |
| 4 | $41.53 | 6,808 | $283K | 13.8% |
| 5 | $42.45 | 2,171 | $92K | 4.5% |
| 6 | $42.45 | 2,171 |
| $92K |
| 4.5% |
| Total | $40.96 avg | 50,000 | $2.0M | 100% |
| Filing → |
| DMTK | SELL | 2022-03-15 | $19K | — | Filing → |
| DMTK | SELL | 2022-03-09 | $43K | — | Filing → |
| DMTK | SELL | 2021-12-16 | $33K | — | Filing → |